|
|
Office Locations:
|
2000 Commonwealth Ave., Suite 200
Auburndale, MA 02466
Phone: 617-244-9050
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
20/20 HealthCare Partners (20/20HCP) provides equity financing for promising growth businesses as well as for buyouts or recapitalizations of established companies specializing in the Medical-Technology industry. 20/20HCP focuses on diagnostic imaging and image enhancement, as well as the evolution of diagnostic imaging and personalized medicine. 20/20HCP reviews various types of investment opportunities from initial pre-seed funding and newly established companies up through mature companies. Projects may be structured as: direct investments, lead investments, strategic alliances, company mergers, growth capital sourcing, strategic consulting, and incubation or operational support. 20/20HCP invests in the fields of Diagnostic Imaging, Medical devices, Healthcare IT, Biotechnology, and pharmaceuticals.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
